Trending now
Lotte Chemical CEO outlines leaner growth path…
Giants’ Lee Jung-hoo continues recent surge with…
Netflix reports earnings after the bell. Here’s…
Airline CEOs urged by lawmaker to lower…
US says its forces ready to restart…
Memorial services held across Korea on 12th…
Why foreign automakers dominate the sedan market
Spirit Airlines could liquidate as early as…
Starbucks launches beta app in ChatGPT to…
AI Studios Disrupts Enterprise Localization with All-in-One…
Home
News
Business
National
Press Release
Finanace
Search for:
Search
Primary Menu
Search for:
Search
Home
Business
FDA vaccine head will step down in April after string of controversial decisions
Business
FDA vaccine head will step down in April after string of controversial decisions
by
Douglas L. Grider
Vinay Prasad is leaving his post as director of the Center for Biologics Evaluation and Research.
previous post
FDA reversals leave investors worrying about the fates of other experimental drugs
next post
[TEST DRIVE] Renault Korea’s Filante set to take on Santa Fe, Sorento
Douglas L. Grider
Related posts
Starbucks union sent the company a proposed contract. Here’s what baristas want
Douglas L. Grider
March 13, 2026
Delta, American raise revenue guidance, citing growth in demand
Douglas L. Grider
March 17, 2026
Peloton is launching bikes and treadmills for gyms, accelerating commercial strategy
Douglas L. Grider
March 16, 2026
